HPV Infections: How Vaccination, Screening, and Prevention Stop Cancer

Human papillomavirus, or HPV, isn’t just a common STI. It’s the leading cause of cervical cancer-and several other cancers too. About 80% of sexually active people will get at least one type of HPV in their lifetime. Most infections clear on their own. But when certain high-risk types stick around, they can silently turn normal cells into precancerous ones. Left unchecked, that can lead to cancer-sometimes over 10 or even 20 years. The good news? We now have powerful tools to stop it before it starts: vaccines, smarter screening, and better access to care.

How HPV Leads to Cancer

There are more than 200 types of HPV. Only about a dozen are high-risk, and among them, HPV 16 and 18 cause about 70% of all cervical cancers. These viruses don’t just infect the cervix-they can also lead to cancers of the anus, throat, penis, vagina, and vulva. The problem isn’t the infection itself. It’s what happens when the virus sticks around long enough to damage DNA in cells. That damage doesn’t happen overnight. It builds slowly, over years. That’s why screening and early detection are so critical.

Before HPV vaccines existed, the Pap test was the only tool we had. It looked for abnormal cell changes under a microscope. But it wasn’t perfect. Many early lesions were missed. That’s why, in recent years, the focus has shifted to testing for the virus itself-before cells even start changing.

The HPV Vaccine: What It Does and Who Needs It

The first HPV vaccine, Gardasil, was approved in 2006. Today, the most widely used version is Gardasil 9. It protects against nine types of HPV, including the two most dangerous (16 and 18) and five others that cause about 20% of additional cancers. The vaccine doesn’t treat existing infections. It prevents them. That’s why timing matters.

The CDC and American Academy of Pediatrics recommend routine vaccination for all children at age 11 or 12. That’s when the immune response is strongest. But it’s still effective if given as early as age 9, and up to age 26 for most people. Adults up to age 45 can also get it-especially if they haven’t been fully vaccinated before. The vaccine cuts the risk of cervical precancers by nearly 90% in people who were vaccinated before exposure.

It’s not just for girls. Boys benefit too. HPV causes throat and anal cancers in men, and vaccinating them helps reduce spread. Studies show that countries with high vaccination rates-like Australia and the UK-have already seen sharp drops in genital warts and precancerous lesions in young women. The vaccine isn’t magic. But when given widely, it changes the curve.

Screening Has Changed-Here’s What You Need to Know

Screening guidelines shifted dramatically after 2020. The old rule-Pap tests every 3 years starting at 21-is outdated. Today, the best approach depends on your age.

• Ages 21-29: Pap test every 3 years. HPV testing isn’t recommended here because infections are common and usually clear on their own. Too much testing can lead to unnecessary procedures.
• Ages 30-65: You have three good options: primary HPV testing every 5 years (the preferred method), Pap test every 3 years, or both tests together (cotesting) every 5 years. Primary HPV testing is more accurate at finding precancers than Pap alone.
• Ages 25-29: The American Cancer Society now recommends primary HPV testing every 5 years as the best option. Other groups still say Pap is fine, but the trend is clear: testing for the virus is better than looking for cell changes after they happen.

Primary HPV testing means looking directly for the DNA or RNA of high-risk HPV types. Two FDA-approved tests are used in the U.S.: the cobas HPV Test by Roche and the Aptima HPV Assay by Hologic. Both detect 14 high-risk types. The cobas test even separates HPV 16 and 18 from the rest, which helps doctors decide how urgently to follow up.

Why does this matter? A 2018 JAMA study found HPV testing catches 94.6% of serious precancers, while Pap tests alone catch only 55.4%. That’s a huge difference. The downside? HPV tests find more positive results, meaning more follow-up visits. But long-term, fewer people develop cancer.

Self-Collected HPV Tests: A Game Changer

One of the biggest barriers to screening? Getting to a clinic. Many women skip screening because of discomfort, cost, transportation, or fear. Self-collected HPV tests change that. You can swab your own vagina at home-just like a COVID test-and mail it in. Studies show it’s almost as accurate as a doctor-collected sample.

In January 2024, Kaiser Permanente officially added self-collected HPV testing to its guidelines for average-risk patients aged 30-64. Their data showed 84.4% sensitivity and 90.7% specificity-close to clinician-collected results. In Australia and the Netherlands, offering self-sampling boosted screening rates by 30-40% among women who hadn’t been screened in years.

The USPSTF now says self-collection should be an option. It’s not just convenient-it’s life-saving. About 30% of cervical cancers happen in women who’ve never been screened. Self-collection could fix that.

What Happens If Your Test Is Positive?

A positive HPV test doesn’t mean you have cancer. It means you have the virus. Most people clear it. But if you’re positive, especially with HPV 16 or 18, you’ll need follow-up.

Standard protocol: If you test positive for HPV 16 or 18, you’re referred for a colposcopy-a closer look at the cervix with a magnifying tool. If you’re positive for other high-risk types, you’ll usually get a Pap test at the same time. If the Pap is abnormal, you go to colposcopy. If it’s normal, you’ll be retested in a year.

This step-by-step approach avoids over-treatment. Not every infection needs surgery. The goal is to catch real precancer, not every virus.

Why Vaccinated People Still Need Screening

A common myth: “If I got the vaccine, I don’t need Pap tests anymore.” That’s false. The vaccine doesn’t cover all high-risk HPV types. It prevents about 90% of cervical cancers-but not all. Plus, not everyone gets the full series, and some people were vaccinated after exposure.

The CDC is clear: vaccinated people should be screened the same as unvaccinated people. Skipping screening because you’re vaccinated puts you at risk. Vaccination is your first line of defense. Screening is your second.

The Global Picture: Progress and Gaps

The World Health Organization set a bold goal in 2020: eliminate cervical cancer by 2050. To get there, countries need to hit three targets by 2030: 90% of girls vaccinated by 15, 70% of women screened by 35 and again by 45, and 90% of precancers and cancers treated.

High-income countries are making progress. In the U.S., cervical cancer rates dropped 50% since the 1970s thanks to screening. But disparities remain. Black women die from cervical cancer at 70% higher rates than White women. In low-income countries, only 19% of women have ever been screened. That’s why tools like self-collection and low-cost HPV tests are so vital.

The global HPV testing market is growing fast-projected to hit $2 billion by 2029. But money alone won’t fix this. Access, education, and trust matter more. In places where women can test themselves at home, screening rates climb. That’s the future.

What’s Next? AI, Longer Intervals, and Better Tools

Technology is catching up. In January 2023, the FDA approved Paige.AI, an AI system that helps pathologists read Pap smears faster and more accurately. Early results show it reduces missed diagnoses.

Research also suggests that after two or three negative HPV tests, screening every 6 years may be safe. A 2023 AACR study found that women with two negative HPV tests had a cancer risk of just 2.3 per 1,000 over six years-lower than the risk after one negative Pap test.

By 2025, experts predict primary HPV testing will be the standard in high-resource settings. That means fewer Pap tests, fewer false alarms, and fewer cancers.

What You Can Do Right Now

• If you’re 9-26: Get the HPV vaccine if you haven’t already.
• If you’re 25-65: Ask your provider about primary HPV testing. It’s now the most effective screening method.
• If you’re nervous about pelvic exams: Ask if self-collected HPV testing is available. It’s safe, private, and just as accurate.
• If you’re over 65: Talk to your doctor. You may still need screening if you’ve never been tested or have a history of precancer.
• If you’ve had a hysterectomy: You likely don’t need screening unless it was for cervical cancer or precancer.

HPV isn’t going away. But cancer from HPV? That’s preventable. The science is clear. The tools exist. What’s missing is action-by individuals, clinics, and systems. Start with the vaccine. Stay on schedule with screening. And don’t let fear or stigma keep you from the care that saves lives.

HPV doesn’t have to mean cancer. With the right steps-vaccination, smart screening, and access to care-it can be stopped before it starts.